The yin and yang of tenascin-R in CNS development and pathology

Progress in Neurobiology

Volumn 61, Issue 5, 2000, Pages 465-493

  Pesheva, Penka ^a   Probstmeier, Rainer ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; TENASCIN;

BRAIN DEVELOPMENT; CELL ADHESION; CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; HUMAN; MORPHOGENESIS; NERVE GROWTH; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; TENASCIN;

EID: 0034257086     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(99)00061-1     Document Type: Review

References (160)

1. Angelov D.N., Walther M., Streppel M., Guntinas-Lichius O., Neiss W.F., Probtsmeier R., Pesheva P. Tenascin-R is antiadhesive for activated microglia that induce downregulation of the protein after peripheral nerve injury: a new role in neuronal protection. J. Neurosci. 18:1998;6218-6229.
2. Arrigo G., Gherzi R., Bonaglia M.C., Leprini A., Zuffardi O., Zardi L. Assignment of the tenascin-R gene (Tnr) to mouse chromosome 4 band E2 by fluorescence in situ hybridization; refinement of the human TNR location to chromosome 1q24. Cytogenet. Cell Genet. 78:1997;145-146.
3. Aspberg A., Binkert C., Rouslahti E. The versican C-type lectin domain recognizes the adhesion protein tenascin-R. Proc. Natl. Acad. Sci. USA. 92:1995;10590-10594.
4. Aspberg A., Miura R., Bourdoulous S., Shimonaka M., Heinegard D., Schachner M., Ruoslahti E., Yamaguchi Y. The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety. Proc. Natl. Acad. Sci. USA. 94:1997;10116-10121.
5. Aufderheide E., Chiquet-Ehrismann R., Ekblom P. Epithelial-mesenchyme interactions in the developing kidney lead to expression of tenascin in the mesenchyme. J. Cell Biol. 105:1987;599-608.
6. Bansal R., Gard A.L., Pfeiffer S.E. Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid. J. Neurosci. Res. 21:1988;260-267.
7. Bansal R., Warrington A.E., Gard A.L., Ranscht B., Pfeiffer S.E. Multiple and novel specificities of monoclonal antibodies O1, O4, R-mAB used in the analysis of oligodendrocyte development. J. Neurosci. Res. 24:1989;548-557.
8. Barres B.A., Raff M.C. Control of oligodendrocyte number in the developing rat optic nerve. Neuron. 12:1994;935-942.
9. Barres B.A., Burne J.F., Holtmann B., Thoenen H., Sendtner M., Raff M.C. Ciliary neurotrophic factor enhances the rate of oligodendrocyte generation. Mol. Cell. Neurosci. 8:1996;146-156.
10. Barres B.A., Lazar M., Raff M.C. A novel role for thyroid hormone, glucocorticoids, and retinoic acid in timing oligodendrocyte differentiation. Development. 120:1994;1097-1108.
11. Barres B.A., Raff M.C., Gaese F., Bartke I., Dechant G., Barde Y.A. A crucial role for neurotrophin-3 in oligodendrocyte development. Nature. 367:1994;371-375.
12. Bartsch S., Bartsch U., Dorries U., Faissner A., Weller A., Ekblom P., Schachner M. Expression of tenascin in the developing and adult cerebellar cortex. J. Neurosci. 12:1992;736-749.
13. Bartsch U., Pesheva P., Raff M., Schachner M. Expression of janusin (J1-160/180) in the retina and optic nerve of the developing and adult mouse. Glia. 9:1993;57-69.
14. Becker C.G., Becker T., Meyer R.L., Schachner M. Tenascin-R inhibits the growth of optic fibers in vitro but is rapidly eliminated during nerve regeneration in the salamander Pleurodeles waltl. J. Neurosci. 19:1999;813-827.
15. Bögler O., Wren D., Barnett S.C., Land H., Noble M. Cooperation between two growth factors promotes extended self-renewal, and inhibits differentiation of O-2A progenitor cells. Proc. Natl. Acad. Sci. USA. 87:1990;6368-6372.
16. Boudreau N.J., Jones P.L. Extracellular matrix and integrin signalling: the shape of things to come. Biochem. J. 339:1999;481-488.
17. Bristow J., Kian Tee M., Gitelman S.E., Mellon S.H., Miller W.L. Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B. J. Cell Biol. 122:1993;265-278.
18. Brümmendorf T., Rathjen F.G. Cell adhesion molecules 1: immunoglobulin superfamily. Protein Profile. 2:1995;963-1058.
19. Brümmendorf T., Hubert M., Treubert U., Leuschner R., Tarnok A., Rathjen F.G. The axonal recognition molecule F11 is a multifunctional protein: specific domains mediate interactions with Ng-CAM and restrictin. Neuron. 10:1993;711-727.
20. Burch G.H., Gong Y., Liu W., Dettman R.W., Curry C.J., Smith L., Miller W.L., Bristow J. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat. Genet. 17:1997;104-108.
21. Burns G.F., Lucas C.M., Krissansen G.W., Werkmeister J.A., Scanlon D.B., Simpson R.J., Vadas M.A. Synergism between membrane gangliosides and Arg-Gly-Asp-directed glycoprotein receptors in attachment to matrix proteins by melanoma cells. J. Cell Biol. 107:1988;1225-1230.
22. Carnemolla B., Castellani P., Ponassi M., Borsi L., Urbini S., Nicolo G., Dorcaratto A., Viale G., Winter G., Neri D., Zardi L. Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody. Am. J. Pathol. 154:1999;1345-1352.
23. Carnemolla B., Leprini A., Borsi L., Querze G., Urbini S., Zardi L. Human tenascin-R. Complete primary structure, pre-mRNA alternative splicing and gene localization on chromosome 1q23-q24. J. Biol. Chem. 14:1996;8157-8160.
24. Caroni P., Schwab M.E. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron. 1:1988;85-96.
25. Celio M.R., Rathjen F.G. Restrictin occurs in 'perineuronal nets' of the adult rat brain. Soc. Neurosci. Abstr. 19:1993;689.
26. Celio M.R., Spreafico R., De Biasi S., Vitellaro-Zuccarello L. Perineuronal nets: past and present. Trends Neurosci. 21:1998;510-515.
27. Cheung N.-K.V., Saarinen U.M., Neely J.E., Landmeier B., Donovan D., Coccia P.F. Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer Res. 45:1985;2642-2649.
28. Chiquet-Ehrismann R. Anti-adhesive molecules of the extracellular matrix. Curr. Opin. Cell Biol. 3:1991;800-804.
29. Chiquet-Ehrismann R. Inhibition of cell adhesion by anti-adhesive molecules. Curr. Opin. Cell Biol. 7:1995;715-719.
30. Chiquet-Ehrismann R., Matsuoka Y., Hofer U., Spring J., Bernasconi C., Chiquet M. Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues. Cell Regul. 2:1991;927-938.
31. Cook G., Tannahill D., Keynes R. Axon guidance to and from choice points. Curr. Opin. Neurobiol. 8:1998;64-72.
32. Copertino D.W., Edelman G.M., Jones F.S. Multiple promoter elements differentially regulate the expression of the mouse tenascin gene. Proc. Natl. Acad. Sci. USA. 94:1997;1846-1851.
33. Crossin K.L., Edelman G.M. Specific binding of cytotactin to sulfated glycolipids. J. Neurosci. Res. 33:1992;631-638.
34. Crossin K.L., Hoffman S., Grumet M., Thiery J.-P., Edelman G.M. Site-restricted expression of cytotactin during development of the chicken embryo. J. Cell Biol. 102:1986;1917-1930.
35. Derr L.B., Chiquet-Ehrismann R., Gandour-Edwards R., Spence J., Tucker R.P. The expression of tenascin-C with the AD1 variable repeat in embryonic tissues, cell lines and tumors in various vertebrate species. Differentiation. 62:1997;71-82.
36. Derr L.B., McKae L.A., Tucker R.P. The distribution of tenascin-R in the developing avian nervous system. J. Exp. Zool. 280:1998;152-164.
37. Dow K.E., Wang W. Cell biology of astrocyte proteoglycans. Cell. Mol. Life Sci. 54:1998;567-581.
38. D'Alessandri L., Ranscht B., Winterhalter K.H., Vaughan L. Contactin/F11 and tenascin-C co-expression in the chick retina correlates with formation of the synaptic plexiform layers. Curr. Eye Res. 14:1995;911-926.
39. Elefteriou F., Exposito J.Y., Garrone R., Lethias C. Characterization of the bovine tenascin-X. J. Biol. Chem. 272:1997;22866-22874.
40. Erickson H.P. Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. Curr. Opin. Cell Biol. 5:1993;869-876.
41. Faissner A. The tenascin gene family in axon growth and guidance. Cell Tissue Res. 290:1997;331-341.
42. Faissner A., Kruse J. J1/Tenascin is a repulsive substrate for central nervous system neurons. Neuron. 5:1990;627-637.
43. Faissner A., Steindler D. Boundaries and inhibitory molecules in developing neural tissues. Glia. 13:1995;233-254.
44. Faissner A., Kruse J., Chiquet-Ehrismann R., Mackie E. The high-molecular-weight J1 glycoproteins are immunochemically related to tenascin. Differentiation. 37:1988;104-114.
45. Faissner A., Kruse J., Kühn K., Schachner M. Binding of the J1 adhesion molecules to extracellular matrix constituents. J. Neurochem. 54:1990;1004-1015.
46. Fawcett J.W. Astrocytic and neuronal factors affecting axon regeneration in the damaged central nervous system. Cell Tissue Res. 290:1997;371-377.
47. Fawcett J.W., Geller H.M. Regeneration in the CNS: optimism mounts. Trends Neurosci. 5:1998;179-180.
48. Fawcett J.W., Fersht N., Housden L., Schachner M., Pesheva P. Axonal growth on astrocytes is not inhibited by oligodendrocytes. J. Cell Sci. 103:1992;571-579.
49. Forsberg E., Hirsch E., Frohlich L., Meyer M., Ekblom P., Aszodi A., Werner S., Fässler R. Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proc. Natl. Acad. Sci. USA. 93:1996;6594-6599.
50. Frost E., Kiernan B.W., Faissner A., ffrench-Constant C. Regulation of oligodendrocyte precursor migration by extracellular matrix: evidence for substrate-specific inhibition of migration by tenascin-C. Dev. Neurosci. 18:1996;266-273.
51. Fuss B., Wintergerst E.S., Bartsch U., Schachner M. Molecular characterization and in situ messenger RNA localization of the neural recognition molecule J1-160/180: a modular structure similar to tenascin. J. Cell Biol. 120:1993;1237-1249.
52. Galvin N.J., Vance P.M., Dixit V.M., Fink B., Frazier W.A. Interaction of human thrombospondin with types I - V collagen: direct binding and electron microscopy. J. Cell Biol. 104:1987;1413-1422.
53. Gard A.L., Pfeiffer S.E. Oligodendrocyte progenitors isolated directly from developing telencephalon at a specific phenotypic stage: myelinogenic potential in a defined environment. Development. 106:1989;119-132.
54. Gary S.C., Kelly G.M., Hockfield S. BEHAB/brevican: a brain-specific lectican implicated in gliomas and glial cell motility. Curr. Opin. Neurobiol. 8:1998;576-581.
55. Gates M.A., Fillmore H., Steindler D.A. Chondroitin sulfate proteoglycan and tenascin in the wounded adult mouse neostriatum in vitro: dopamine neuron attachment and process outgrowth. J. Neurosci. 16:1996;8005-8018.
56. Gherzi R., Leprini A., Siri A., Zardi L. Structure of the 5′ region of human tenascin-R gene and characterization of its promoter. DNA Cell Biol. 17:1998;275-282.
57. Goldbrunner R.H., Bernstein J.J., Tonn J.C. ECM-mediated glioma cell invasion. Microsc. Res. Tech. 43:1998;250-257.
58. Goodman C.S. Mechanisms and molecules that control growth cone guidance. Annu. Rev. Neurosci. 19:1996;341-377.
59. Götz M., Bolz J., Joester A., Faissner A. Tenascin-C synthesis and influence on axonal growth during rat cortical development. Eur. J. Neurosci. 9:1997;496-506.
60. Grumet M., Hoffman S., Crossin K.L., Edelman G.M. Cytotactin. An extracellular matrix protein of neural and non-neural tissues that mediates glia-neuron interaction. Proc. Natl. Acad. Sci. USA. 82:1985;8075-8079.
61. Gumbiner B. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell. 84:1996;345-357.
62. Hagihara K., Miura R., Kosaki R., Berglund E., Ranscht B., Yamaguchi Y. Immunohistochemical evidence for the brevican-tenascin-R interaction: colocalization in perineuronal nets suggests a physiological role for the interaction in the adult brain. J. Comp. Neurol. 410:1999;256-264.
63. Hagios C., Koch M., Spring J., Chiquet M., Chiquet-Ehrismann R. Tenascin-Y: a protein of novel domain structure is secreted by differentiated fibroblasts of muscle connective tissue. J. Cell Biol. 134:1996;1499-1512.
64. Hannun Y.A., Bell R.M. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science. 243:1989;500-507.
65. Hannun Y.A., Loomis C.R., Merrill A.H. Jr., Bell R.M. Sphingosine inhibition of protein kinase C activity and of phorboldibutyrate binding in vitro and in human platelets. J. Biol. Chem. 261:1986;12604-12609.
66. Hasegawa K., Yoshida T., Matsumoto K., Katsuta K., Waga S., Sakakura T. Differential expression of tenascin-C and tenascin-X in human astrocytomas. Acta Neuropathol. 93:1997;431-437.
67. Hayashi M., Yamada K.M. Divalent cation modulation of fibronectin binding to heparin and to DNA. J. Biol. Chem. 257:1982;5263-5267.
68. Hoffman S., Crossin K.L., Edelman G.M. Molecular forms, binding functions, and developmental expression patterns of cytotactin and cytotactin-binding proteoglycan, an interactive pair of extracellular matrix molecules. J. Cell Biol. 106:1988;519-532.
69. Ibarrola N., Mayer-Pröschel M., Rodriguez-Pena A., Noble M. Evidence for the existence of at least two timing mechanisms that contribute to oligodendrocyte generation in vitro. Develop. Biol. 180:1996;1-21.
70. Isom L.L., Ragsdale D.S., De Jongh K.S., Westenbroek R.E., Reber B.F.X., Scheuer T., Catterall W.A. Structure and function of the beta2 subunit of brain sodium channels, a transmembrane glycoprotein with a CAM motif. Cell. 83:1995;433-442.
71. Joester A., Faissner A. Evidence for the combinatorial variability of tenascin-C isoforms and developmental regulation in the mouse central nervous system. J. Biol. Chem. 274:1999;17144-17151.
72. Jung M., Pesheva P., Schachner M., Trotter J. Astrocytes and neurons regulate the expression of the neural recognition molecule janusin by cultured oligodendrocytes. Glia. 9:1993;163-175.
73. Kammerer R.A., Schulthess T., Landwehr R., Lustig A., Fischer D., Engel J. Tenascin-C hexabrachion assembly is a sequential two-step process initiated by coiled-coil alpha-helices. J. Biol. Chem. 273:1998;10602-10608.
74. Kaplony A.D., Zimmermann R., Fischer R.W., Imhof B.A., Odermatt B.F., Winterhalter K.H., Vaughan L. Tenascin Mr 220,000 isoform expression correlates with corneal cell migration. Development. 112:1991;605-614.
75. Kiernan B.W., Götz B., Faissner A., ffrench-Constant C. Tenascin-C inhibits oligodendrocyte precursor cell migration by both adhesion-dependent and adhesion-independent mechanisms. Mol. Cell. Neurosci. 7:1996;322-335.
76. Kruse J., Keilhauer G., Faissner A., Timpl R., Schachner M. The J1 glycoprotein - a novel nervous system cell adhesion molecule of the L2/HNK-1 family. Nature. 316:1985;146-148.
77. Kruse J., Mailhammer R., Wernecke H., Faissner A., Sommer I., Goridis C., Schachner M. Neural cell adhesion molecules and myelin-associated glycoprotein share a common carbohydrate moiety recognized by monoclonal antibodies L2 and HNK-1. Nature. 311:1984;153-155.
78. Leprini A., Gherzi R., Vecchi E., Borsi I., Zardi L., Siri A. Rat tenascin-R gene: structure, chromosome location and transcriptional activity of promoter and exon 1. Cytogenet. Cell Genet. 83:1998;115-123.
79. LeVine S.M., Goldman J.E. Spatial and temporal patterns of oligodendrocyte differentiation in rat cerebrum and cerebellum. J. Comp. Neurol. 277:1988;441-455.
80. Mackie E.J. Molecules in focus: tenascin-C. Int. J. Biochem. Cell Biol. 29:1997;1133-1137.
81. Mackie E.J., Chiquet-Ehrismann R., Pearson C.A., Inaguma Y., Taya K., Kawarada Y., Sakakura T. Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc. Natl. Acad. Sci. USA. 84:1987;4621-4625.
82. Mackie E.J., Halfter W., Liverani D. Induction of tenascin in healing wounds. J. Cell Biol. 107:1988;2757-2767.
83. Mackie E.J., Abraham L.A., Taylor S.L., Tucker R.P., Murphy L.I. Regualtion of tenascin-C expression in bone cells by transforming growth factor-beta. Bone. 22:1998;301-307.
84. Mackie E.J., Tucker R.P. The tenascin-C knockout revisited. J. Cell Sci. 112:1999;3847-3853.
85. Margolis R.U., Margolis R.K. Chondroitin sulfate proteoglycans as mediators of axon growth and pathfinding. Cell Tissue Res. 290:1997;343-348.
86. Martini R., Schachner M., Faissner A. Enhanced expression of the extracellular matrix molecule J1/tenascin in the regenerating adult mouse sciatic nerve. J. Neurocytol. 19:1990;601-616.
87. Matsumoto K.I., Saga Y., Ikemura T., Sakakura T., Chiquet-Ehrismann R. The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C. J. Cell Biol. 125:1994;483-493.
88. Mayer M., Bhakoo K., Noble M. CNTF and LIF promote the generation, maturation and survival of oligodendrocytes in vitro. Development. 120:1994;143-153.
89. McKinnon R.D., Matsui T., Dubois-Dalcq M., Aaronson S.A. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron. 5:1990;603-614.
90. Merrill J.E., Benveniste E.N. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19:1996;331-338.
91. Milev P., Chiba A., Haring M., Rauvala H., Schachner M., Ranscht B.K.M.R., Margolis R.U. High affinity binding and overlapping localization of neurocan and phosphacan/protein tyrosine phosphatase-zeta/beta with tenascin-R, amphoterin, and the heparin-binding growth-associated molecule. J. Biol. Chem. 273:1998;6998-7005.
92. Miller R.H. Oligodendrocyte origins. Trends Neurosci. 19:1996;92-96.
93. Moore S., Thanos S. The concept of microglia in relation to central nervous system disease and regeneration. Prog. Neurobiol. 48:1996;441-460.
94. Morganti M.C., Taylor J., Pesheva P., Schachner M. Oligodendrocyte-derived J1-160/180 extracellular matrix glycoproteins are adhesive or repulsive depending on the partner cell type and time of interaction. Exp. Neurol. 109:1990;98-110.
95. Mueller B.K. Growth cone guidance: first steps towards a deeper understanding. Annu. Rev. Neurosci. 22:1999;351-388.
96. Noble M. Points of controversy in the O-2A lineage: clocks and type-2 astrocytes. Glia. 4:1991;157-164.
97. Nörenberg U., Hubert M., Rathjen F.G. Structural and functional characterization of tenascin-R (restrictin), an extracellular matrix glycoprotein of glial cells and neurons. Int. J. Dev. Neurosci. 14:1996;217-231.
98. Nörenberg U., Hubert M., Brümmendorf T., Tarnok A., Rathjen F.G. Characterization of functional domains of the tenascin-R (restrictin) polypeptide: cell attachment site, binding with F11, and enhancement of F11-mediated neurite outgrowth by tenascin-R. J. Cell Biol. 130:1995;473-484.
99. Nörenberg U., Wille H., Wolff J.M., Frank R., Rathjen F.G. The chicken neural extracellular matrix molecule restrictin: similarity with EGF-, fibronectin type III-, and fibrinogen-like motifs. Neuron. 8:1992;849-863.
100. Paulus W., Baur I., Schuppan D., Roggendorf W. Characterization of integrin receptors in normal and neoplastic human brain. Am. J. Pathol. 143:1993;154-163.
101. Pesheva P., Gennarini G., Goridis C., Schachner M. The F3/11 cell adhesion molecule mediates the repulsion of neurons by the extracellular matrix glycoprotein J1-160/180. Neuron. 10:1993;69-82.
102. Pesheva P., Gloor S., Schachner M., Probstmeier R. Tenascin-R is an intrinsic autocrine factor for oligodendrocyte differentiation and promotes cell adhesion by a sulfatide-mediated mechanism. J. Neurosci. 17:1997;4642-4651.
103. Pesheva P., Probstmeier R., Skubitz A.P.N., McCarthy J.B., Furcht L.T., Schachner M. Tenascin-R (J1 160/180) inhibits fibronectin-mediated adhesion: functional relatedness to tenascin-C. J. Cell Sci. 107:1994;2323-2333.
104. Pesheva P., Probstmeier R., Spiess E., Schachner M. Divalent cations modulate the inhibitory substrate properties of murine glia-derived J1-160 and J1-180 extracellular matrix glycoproteins for neuronal adhesion. Eur. J. Neurosci. 3:1991;356-365.
105. Pesheva P., Spiess E., Schachner M. J1-160 and J1-180 are oligodendrocyte-secreted nonpermissive substrates for cell adhesion. J. Cell Biol. 109:1989;1765-1778.
106. Pires Neto M.A., Braga-de-Souza S., Lent R. Extracellular matrix molecules play diverse roles in the growth and guidance of central nervous system axons. Braz. J. Med. Biol. Res. 32:1999;633-638.
107. Prieto A.L., Jones F.S., Cunningham B.A., Crossin K.L., Edelman G.M. Localization during development of alternatively-spliced forms of cytotactin by in situ hybridization. J. Cell Biol. 111:1990;685-698.
108. Probstmeier R., Pesheva P. I-type lectins in the nervous system. Progress Neurobiol. 58:1999;163-184.
109. 1 integrin-dependent cell adhesion and neurite outgrowth on fibronectin by a disialoganglioside-mediated signaling mechanism. Glycobiology. 9:1999;101-114.
110. Probstmeier, R., Braunewell, K.-H., Pesheva, P. 1999a. Involvement of chondroitin sulfates expressed on tenascin-R in carbohydrate-dependent interactions with fibronectin and tenascin-C (submitted).
111. Probstmeier R., Michels M., Franz T., Chan B.M.C., Pesheva P. Tenascin-R interferes with integrin-dependent oligodendrocyte precursor cell adhesion by a ganglioside-mediated signalling mechanism. Eur. J. Neurosci. 11:1999;2474-2488.
112. Probstmeier, R., Stichel, C.C., Müller, H.W., Asou, H., Pesheva, P. 1999c. Chondroitin sulfates expressed on oligodendrocyte-derived tenascin-R are involved in neural cell recognition: functional implications during CNS development and regeneration J. Neurosci. Res. (in press).
113. Prohaska J.R. Functions of trace elements in brain metabolism. Physiol. Rev. 67:1987;858-901.
114. Rathjen F.G., Wolff J.M., Chiquet-Ehrismann R. Restrictin: an extracellular matrix glycoprotein involved in cell attachment co-purifies with the cell recognition molecule F11. Development. 113:1991;151-164.
115. Rauch U. Modeling an extracellular environment for axonal pathfinding and fasciculation in the central nervous system. Cell Tissue Res. 290:1997;349-356.
116. Riou J.-F., Umbhauer M., Shi D.L., Boucaut J.-C. Tenascin: a potential modulator of cell-extracellular matrix interactions during vertebrate embryogenesis. Biol. Cell. 75:1992;1-9.
117. Ruoslahti E. Brain extracellular matrix. Glycobiology. 6:1996;489-492.
118. Saga Y., Yagi T., Ikawa Y., Sakakura T., Aizawa S. Mice develop normally without tenascin. Genes Dev. 6:1992;1821-1831.
119. Schachner M., Taylor J., Bartsch U., Pesheva P. The perplexing multifunctionality of janusin, a tenascin-related molecule. Perspectives Devel. Neurobiol. 2:1994;33-42.
120. Scheffler B., Faissner A., Beck H., Behle K., Wolf H.K., Wiestler O.D., Blümcke I. Hippocampal loss of tenascin boundaries in Ammon's horn sclerosis. Glia. 19:1997;35-46.
121. Schumacher S., Volkmer H., Buck F., Otto A., Tarnok A., Roth S., Rathjen F.G. Chicken acidic leucine-rich EGF-like domain containing brain protein (CALEB), a neural member of the EGF family of differentiation factors, is implicated in neurite formation. J. Cell Biol. 136:1997;895-906.
122. Schwab M.E., Bartholdi D. Degeneration and regeneration of axons in the lesioned spinal cord. Physiol. Rev. 76:1996;319-370.
123. Scolding N.J., Zajicek J.P., Wood N., Compston D.A.S. The pathogenesis of demyelinating disease. Progress Neurobiol. 43:1994;143-173.
124. Seilheimer B., Schachner M. Regulation of neural cell adhesion molecule expression on cultured mouse Schwann cells by nerve growth factor. EMBO J. 6:1987;1611-1616.
125. Seilheimer B., Schachner M. Studies of adhesion molecules mediating interactions between cells of peripheral nervous system indicate a major role for L1 in mediating sensory neuron growth on Schwann cells in culture. J. Cell Biol. 107:1988;341-351.
126. Serpente N., Birling M.-C., Price J. The regulation of the expression, phosphorylation, and protein associations of pp125FAK during rat brain development. Mol. Cell. Neurosci. 7:1996;391-403.
127. Sivron T., Schwartz M. The enigma of myelin-associated growth inhibitors in spontaneously regenerating nervous systems. Trends Neurosci. 17:1994;277-281.
128. Sobel R.A. The extracellular matrix in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 57:1998;205-217.
129. Song H.-j., Poo M.-m. Signal transduction underlying growth cone guidance by diffusible factors. Curr. Opin. Neurobiol. 9:1999;355-363.
130. Spillmann A.A., Bandtlow C.E., Lottspeich F., Keller F., Schwab M.E. Identification and characterization of a bovine neurite growth inhibitor (bNI-220). J. Biol. Chem. 273:1998;19283-19293.
131. Srinivasan J., Schachner M., Catterall W.A. Interaction of voltage-gated sodium channels with the extracellular matrix molecules tenascin-C and tenascin-R. Proc. Natl. Acad. Sci. USA. 95:1998;15753-15757.
132. Stichel C.C., Müller H.W. The CNS lesion scar: new vistas on an old regeneration barrier. Cell Tissue Res. 294:1998;1-9.
133. Streit W.J., Walter S.A., Pennell N.A. Reactive microgliosis. Prog. Neurobiol. 57:1999;563-581.
134. Taylor H.C., Lightner V.A., Beyer W.F., McCaslin D., Briscoe G., Erickson H.P. Biochemical and structural studies of tenascin/hexabrachion proteins. J. Cell. Biochem. 47:1989;71-90.
135. Taylor J., Pesheva P., Schachner M. Influence of janusin and tenascin on growth cone behavior in vitro. J. Neurosci. Res. 35:1993;347-362.
136. Tucker R.P. The in situ localization of tenascin splice variants and thrombospondin 2 mRNA in the avian embryo. Development. 117:1993;347-358.
137. Tucker R.P., McKay S.E. The expression of tenascin by neural crest cells and glia. Development. 112:1991;1031-1039.
138. Tucker R.P., Hagios C., Chiquet-Ehrismann R. Tenascin-Y in the developing and adult avian nervous system. Dev. Neurosci. 21:1999;126-133.
139. Volkmer H., Zacharias U., Norenberg U., Rathjen F.G. Dissection of complex molecular interactions of neurofascin with axonin-1, F11, and tenascin-R, which promote attachment and neurite formation of tectal cells. J. Cell Biol. 142:1998;1083-1093.
140. von Holst H., Nygren C., Bostrom K., Collins V.P., Fredman P. The presence of foetal ganglioside antigens 3'-isoLM1 and 3'6'-isoLD1 in both glioma tissue and surrounding areas from human brain. Acta Neurochir. Wien. 139:1997;141-145.
141. Vos J.P., Gard A.L., Pfeiffer S.E. Regulation of oligodendrocyte cell survival and differentiation by ciliary neurotrophic factor, leukemia inhibitory factor, oncostatin M, and interleukin-6. Perspectives Devel. Neurobiol. 4:1996;39-52.
142. Wallach D., Boldin M., Varfolomeev E., Belayert R., Vandenabeele P., Fiers W. Cell death induction by receptors of the TNF family: towards a molecular understanding. FEBS Lett. 410:1997;96-106.
143. Weber P., Bartsch U., Rasband M.N., Czaniera R., Lang Y., Bluethmann H., Margolis R.U., Levison S.R., Shrager P., Montag D., Schachner M. Mice deficient for tenascin-R display alterations of the extracellular matrix and decreased axonal conduction velocities in the CNS. J. Neurosci. 19:1999;4245-4262.
144. Weber P., Montag D., Schachner M., Bernhardt R.R. Zebrafish tenascin-W, a new member of the tenascin family. J. Neurobiol. 35:1998;1-16.
145. Wehrle-Haller B., Koch M., Baumgartner S., Spring J., Chiquet M. Nerve-dependent and-independent tenascin expression in the developing chick limb bud. Development. 112:1991;627-637.
146. Wintergerst E.S., Fuss B., Bartsch U. Localization of janusin mRNA in the central nervous system of the developing and adult mouse. Eur. J. Neurosci. 5:1993;299-309.
147. Wintergerst E.S., Vogt Weisenhorn D.M., Rathjen F.G., Riederer B.M., Lambert S., Celio M.R. Temporal and spatial appearance of the membrane cytoskeleton and perineuronal nets in the rat neocortex. Neurosci. Lett. 209:1996;173-176.
148. Xiao Z.C., Bartsch U., Margolis R.K., Rougon G., Montag D., Schachner M. Isolation of tenascin-R binding protein from mouse brain membranes. A phosphacan-related chondroitin sulfate proteoglycan. J. Biol. Chem. 272:1997;32092-32101.
149. Xiao Z.C., Taylor J., Montag D., Rougon G., Schachner M. Distinct effects of recombinant tenascin-R domains in neuronal cell functions and identification of the domain interacting with the neuronal recognition molecule F3/11. Eur. J. Neurosci. 8:1996;766-782.
150. Xiao Z.C., Hillenbrand R., Schachner M., Thermes S., Rougon G., Gomez S. Signaling events following the interaction of the neuronal adhesion molecule F3 with the N-terminal domain of tenascin-R. J. Neurosci. Res. 49:1997;698-709.
151. Xiao Z.C., Revest J.M., Laeng P., Rougon G., Schachner M., Montag D. Defasciculation of neurites is mediated by tenascin-R and its neuronal receptor F3/11. J. Neurosci. Res. 52:1998;390-404.
152. Yamaguchi Y. Brevican: a major proteoglycan in adult brain. Perspect. Dev. Neurobiol. 3:1996;307-317.
153. Yang L.J.-S., Zeller C.B., Shaper N.L., Kiso M., Hasegawa A., Shapiro R.E., Schnaar R.L. Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc. Natl. Acad. Sci. USA. 93:1996;814-818.
154. Yang Z., Mendoza A.R., Welch T.R., Zipf W.B., Yu C.Y. Modular variations of the human major histocompatibility complex class III genes for serine/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX module). A mechanism for gene deletions and disease associations. J. Biol. Chem. 274:1999;12147-12156.
155. Yurchenco P.D., O'Rear J. Supramolecular organization of basement membranes. 1993;Academic Press, San Diego.
156. Zacharias U., Nörenberg U., Rathjen F.G. Functional interactions of the immunoglobulin superfamily member F11 are differentially regulated by the extracellular matrix proteins tenascin-R and tenascin-C. J. Biol. Chem. 274:1999;24357-24365.
157. Zagzag D., Friedlander D.R., Miller D.C., Dosik J., Cangiarella J., Kostianovsky M., Cohen H., Grumet M., Greco M.A. Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res. 55:1995;907-914.
158. Zamze S., Harvey D.J., Pesheva P., Mattu T.S., Schachner M., Dwek R.A., Wing D.R. Glycosylation of a CNS-specific extracellular matrix glycoprotein, tenascin-R, is dominated by O-linked sialylated glycans and 'brain-type' neutral N-glycans. Glycobiology. 9:1999;823-831.
159. Zisch A.H., D'Alessandri L., Amrein K., Ranscht B., Winterhalter K.H., Vaughan L. The glypiated neuronal cell adhesion molecule contactin/F11 complexes with src-family protein tyrosine kinase Fyn. Mol. Cell. Neurosci. 6:1995;263-279.
160. Zisch A.H., D'Alessandri L., Ranscht B., Falchetto R., Winterhalter K.H., Vaughan L. Neuronal cell adhesion molecule contactin/F11 binds to tenascin via its immunoglobulin-like domains. J. Cell Biol. 119:1992;203-213.